Posts

CDC recommends updated Covid vaccines for everyone 6 mo...

A CDC analysis suggested that a universal recommendation for updated Covid vacci...

Food companies to regulators: Please don’t worry about ...

Food companies are pleading with regulators not to focus their attention on ultr...

STAT+: White House touts efforts to stem cancer drug sh...

The White House outlined its efforts to end shortages of three key generic chemo...

STAT+: Neurocrine Biosciences drug for congenital adren...

Neurocrine Biosciences announced on Tuesday that an experimental drug for congen...

Popular nasal decongestant doesn’t actually relieve con...

The leading decongestant used by millions of Americans looking for relief from a...

STAT+: Walmart may buy concierge Medicare Advantage pro...

Experts largely hailed Walmart's rumored acquisition of Medicare Advantage provi...

Is there a path forward for PEPFAR?

Lawmakers are growing less optimistic about a full-reauthorization for PEPFAR, t...

STAT+: Pharmalittle: Is Pascal Soriot leaving AstraZene...

AstraZeneca appeared to play down speculation about CEO Pascal Soriot after a U....

STAT+: Nick Leschly departs Bluebird Bio spinout amid r...

Some two years after splitting biotech company Bluebird Bio into two entities, t...

STAT+: New obesity drugs are in the works trying to out...

Hunting for the next Ozempic, dozens of companies are pursuing various combinati...

Opinion: Patients might finally receive practical infor...

The FDA can’t fall for these five myths that often undermine health communications.

The food industry has tried to stack a key nutrition po...

There’s a panel of 20 nutrition experts that has outsized influence on the Ameri...

STAT+: Here are the dozens of weight loss drugs in deve...

Want to know which drugs could soon compete with Wegovy or Mounjaro? The STAT Ob...

STAT+: FDA proposes changes to key approval pathway for...

The FDA issued new guidelines clarifying the way they plan to evaluate medical d...

STAT+: Acelyrin, a rare IPO success, stumbles in its fi...

Acelyrin, which raised more than $500 million in an IPO this year, ran into its ...

FDA approves updated Covid vaccines

The FDA announced Monday that it had greenlit two updated Covid-19 booster shots...